Situación actual de los stents liberadores de fármacos: nuevos desafíos y nuevas dudas. Introducción

Togni, 2004, Working Group, Interventional Cardiology and Coronary Pathophysiology, European Society of Cardiology. Percutaneous coronary interventions in Europe 1992-2001, Eur Heart J, 25, 1208, 10.1016/j.ehj.2004.04.024 Gruntzig, 1979, Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty, N Engl J Med, 301, 61, 10.1056/NEJM197907123010201 Fischman, 1994, A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease, N Engl J Med, 331, 496, 10.1056/NEJM199408253310802 Serruys, 1994, A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Stydy Group, N Engl J Med, 331, 489, 10.1056/NEJM199408253310801 Rajagopal, 2003, Coronary restenosis: a review of mechanisms and management, Am J Med, 115, 547, 10.1016/S0002-9343(03)00477-7 Serruys, 1991, Angiographic follow-up after placement of a self-expanding coronary-artery stent, N Engl J Med, 324, 13, 10.1056/NEJM199101033240103 Leon, 1998, A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators, N Engl J Med, 339, 1665, 10.1056/NEJM199812033392303 Narins, 2004, Reestenosis dentro de endoprótesis vasculares, 469 Serruys, 2005, Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial, J Am Coll Cardiol, 46, 575, 10.1016/j.jacc.2004.12.082 2002, Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial, Lancet, 360, 965, 10.1016/S0140-6736(02)11078-6 Adamian, 2001, Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty, J Am Coll Cardiol, 38, 672, 10.1016/S0735-1097(01)01458-9 Sabaté, 2001, Estado actual de la braquiterapia intracoronaria, Rev Esp Cardiol, 54, 1197, 10.1016/S0300-8932(01)76479-2 Moreno, 2005, Stents recubiertos y otros dispositivos antireestenosis, Rev Esp Cardiol, 58, 842, 10.1157/13077236 Morice, 2002, Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions, N Engl J Med, 346, 1773, 10.1056/NEJMoa012843 Grube, 2003, TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions, Circulation, 107, 38, 10.1161/01.CIR.0000047700.58683.A1 Colombo, 2003, Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions, Circulation, 108, 788, 10.1161/01.CIR.0000086926.62288.A6 Regar, 2002, El estudio RAVEL. Reestenosis del cero por ciento: ¡un sueño del cardiólogo hecho realidad!, Rev Esp Cardiol, 55, 459, 10.1016/S0300-8932(02)76634-7 Moses, 2003, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, 1315, 10.1056/NEJMoa035071 Schofer, 2003, Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS), Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Schampaert, 2004, The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS), J Am Coll Cardiol, 43, 1110, 10.1016/j.jacc.2004.01.024 Stone, 2004, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med, 350, 221, 10.1056/NEJMoa032441 Stone, 2005, Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial, JAMA, 294, 1215, 10.1001/jama.294.10.1215 Dawkins, 2005, Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial, Circulation, 112, 3306, 10.1161/CIRCULATIONAHA.105.552190 Lemos, 2004, Unrestricted utilization of sirolimus-eluting stent compared with conventional bare stent implantation in the «realworld», Circulation, 109, 190, 10.1161/01.CIR.0000109138.84579.FA Lemos, 2004, Clinical, angiographic and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients, Circulation, 109, 1366, 10.1161/01.CIR.0000121358.26097.06 Ong, 2005, The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population, J Am Coll Cardiol, 45, 1135, 10.1016/j.jacc.2005.01.008 Pfisterer, 2006, Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents, J Am Coll Cardiol, 48, 2584, 10.1016/j.jacc.2006.10.026 Bavry, 2006, Late Trombosis of drug-eluting stents: a meta-analysis of randomized clinical trials, Am J Med, 119, 1056, 10.1016/j.amjmed.2006.01.023 Colombo, 2006, Drug-eluting stent thrombosis. Increasingly recognized but too frequently overemphasized, J Am Coll Cardiol, 48, 203, 10.1016/j.jacc.2006.04.040 Hodgson, 2007, Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents. A report from the Society for Cardiovascular Angiography and Interventions Drug-Eluting stent Task Force, Catheter Cardiovasc Interv, 69, 327, 10.1002/ccd.21093 Leon, 2007, Late thrombosis a concern with drug-eluting stents, J Interven Cardiol, 20, 26, 10.1111/j.1540-8183.2007.00225.x Daemen, 2007, Early and late coronary stent thrombosis of sirolimusand paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study, Lancet, 369, 667, 10.1016/S0140-6736(07)60314-6 Camenzind E. Safety of drug-eluting stents: Insights from meta-analysis. [accedido 7 Feb 2007]. Disponible en: http://www.escardio.org/knowledge/congresses/CongressReports/hotlinesandctus/707009_Camenzind Nordmann, 2006, Mortality in randomized controlled trials comparing drug-eluting vs bare metal stents in coronary artery disease: a meta-analysis, Eur Heart J, 27, 2784, 10.1093/eurheartj/ehl282 Holmes, 2006, Cause of death with bare metal and sirolimus-eluting stents, Eur Heart J, 27, 2815, 10.1093/eurheartj/ehl385 Honda, 2003, Stent thrombosis. An issue revisited in a changing world, Circulation, 108, 2, 10.1161/01.CIR.0000075929.79964.D8 Cutlip, 2001, Stent thrombosis in the modern era. A pooled analysis of multicenter coronary stent clinical trials, Circulation, 103, 1967, 10.1161/01.CIR.103.15.1967 Lakovou, 2005, Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126 Kuchulakanti, 2006, Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents, Circulation, 113, 1108, 10.1161/CIRCULATIONAHA.105.600155 Shuchman, 2006, Trading restenosis for thrombosis? New questions about drug-eluting stents, N Engl J Med, 355, 1949, 10.1056/NEJMp068234 Spaulding, 2007, A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 989, 10.1056/NEJMoa066633 Stone, 2007, Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents, N Engl J Med, 356, 998, 10.1056/NEJMoa067193 Kastrati, 2007, Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 1030, 10.1056/NEJMoa067484 Chen, 2006, Bare metal stent restenosis is not a benign clinical entity, Am Heart J, 151, 1260, 10.1016/j.ahj.2005.08.011 Walters, 2002, Acute coronary syndrome is a common clinical presentation of in-stent restenosis, Am J Cardiol, 89, 491, 10.1016/S0002-9149(01)02285-8 Assali, 2006, Acute coronary syndrome may occur with instent restenosis and is associated with adverse outcomes (the PRESTO trial), Am J Cardiol, 98, 729, 10.1016/j.amjcard.2006.04.007 Mauri, 2007, Stent thrombosis in randomized clinical trials of drug-eluting stents, N Engl J Med, 356, 1020, 10.1056/NEJMoa067731 Moreno, 2005, Drug-eluting stent trombosis. Results from a pooled analysis including 10 randomized studies, J Am Coll Cardiol, 45, 954, 10.1016/j.jacc.2004.11.065 Lüscher, 2007, Drug-eluting stent and coronary thrombosis. Biological mechanisms and clinical implications, Circulation, 115, 1051, 10.1161/CIRCULATIONAHA.106.675934 Nebeker, 2006, Hipersensivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Events and Reports (RADAR) project, J Am Coll Cardiol, 47, 175, 10.1016/j.jacc.2005.07.071 Lee, 2007, Stent fracture associated with drug-eluting stents: clinical characteristics and implications, Catheter Cardiovasc Inter, 69, 387, 10.1002/ccd.20942 Ako, 2005, Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis, J Am Coll Cardiol, 46, 1002, 10.1016/j.jacc.2005.05.068 Joner, 2006, Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk, J Am Coll Cardiol, 48, 193, 10.1016/j.jacc.2006.03.042 Kotani, 2006, Incomplete neointimal coverage of sirolimus-eluting stents. Angioscopic findings, J Am Coll Cardiol, 47, 2108, 10.1016/j.jacc.2005.11.092 Oyabu, 2006, Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent, Am Heart J, 152, 1168, 10.1016/j.ahj.2006.07.025 Matsumoto D, Shite J, Shinhe T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up evaluated by optical coherence tomography. Eur Heart J [accedido 29 Nov 2006]. Disponible en: 10.1093/eurheartj/ehl413 Jeremias, 2004, Stent thrombosis after successful sirolimus-eluting stent implantation, Circulation, 109, 1930, 10.1161/01.CIR.0000127105.99982.21 Smith SC Jr, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention. Disponible en: www.acc.org/clinical/guidelines/percutaneous/update/index_rev.pdf Eisenstein, 2007, Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation, JAMA, 297, 159, 10.1001/jama.297.2.joc60179 Grines, 2007, Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents, J Am Coll Cardiol, 49, 734, 10.1016/j.jacc.2007.01.003 Maisel, 2007, Unanswered questions- Drug-eluting stents and the risk of late thrombosis, N Engl J Med, 356, 981, 10.1056/NEJMp068305 Lagerqvist, 2007, Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden, N Engl J Med, 356, 1009, 10.1056/NEJMoa067722 Oliva, 2006, Coste-efectividad de los stents liberadores de fármacos: implicaciones para la práctica clínica y el coste sanitario, Rev Esp Cardiol, 59, 865, 10.1157/13093251 Ong, 2006, Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up. Results from the RESEARCH registry, Eur Heart J, 27, 2996, 10.1093/eurheartj/ehl357 Ong, 2005, Technology Insight: an overview of research in drug-eluting stents, Nat Clin Pract Cardiovasc Med, 12, 647, 10.1038/ncpcardio0378 Waksman, 2006, Update on bioabsorbable stents: from bench to clinical, J Interv Cardiol, 19, 414, 10.1111/j.1540-8183.2006.00187.x Aoki, 2005, Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry, J Am Coll Cardiol, 45, 1574, 10.1016/j.jacc.2005.01.048